Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021)

Lemaitre Vascular's (LMAT) quarterly Short term Debt came in at $3.0 million in Q2 2021, up 50.0% year-on-year from $2.0 million in Q2 2020, and up 20.0% on a QoQ basis from $2.5 million in Q4 2020.

Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021) Analysis & Trends

Lemaitre Vascular (LMAT) has 2 years of Short term Debt data on file, last reported at $3.0 million in Q2 2021.

  • On a quarterly basis, Short term Debt rose 50.0% year-over-year to $3.0 million in Q2 2021; TTM through Jun 2021 was $3.0 million, a 50.0% increase from a year earlier, with the FY2020 full-year figure at $2.5 million, changed N/A from the prior year.
  • Short term Debt for Q2 2021 stood at $3.0 million, up from $2.5 million in the prior quarter.
  • Over the last five years, Short term Debt for LMAT reached as high as $3.0 million in Q2 2021 and fell as low as $2.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Lemaitre Vascular 2.22 Bn 1.86 Bn 48.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2021 3.00 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 2.25 Mn
Jun 30, 2020 2.00 Mn